Ajanta Pharmaceuticals Profit & Loss Annual

Trade
BSE: 532331 | NSE: AJANTPHARM | ISIN: INE031B01049 | Sector: Biotechnology & Drugs
2,391.85 +12.10 (0.51%)Updated : 18 May 2024
Fiscal Period2024202320222021
Period End DateMar 24Mar 23Mar 22Mar 21
Revenue 4,208.713,742.643,340.992,889.69
Total Revenue 4,208.713,742.643,340.992,889.69
Costof Revenue Total 1,066.571,116.73886.72682.39
Gross Profit 3,142.142,625.912,454.272,207.30
Selling/ General/ Admin Expenses Total 900.341,774.381,481.721,171.06
Depreciation/ Amortization 135.40130.31124.82115.60
Other Operating Expenses Total 1,069.8640.1335.3927.91
Total Operating Expense 3,172.173,062.042,533.122,005.01
Operating Income 1,036.54680.60807.87884.68
Interest Inc( Exp) Net- Non- Op Total -72.10646.90901.90121.10
Other Net 84.606.1515.295.60
Net Income Before Taxes 1,113.93745.25909.48900.18
Provisionfor Income Taxes 297.76157.27196.79246.31
Net Income After Taxes 816.17587.98712.69653.87
Net Income Before Extra Items 816.17587.98712.69653.87
Net Income 816.17587.98712.69653.87
Income Availableto Com Excl Extra Ord 816.17587.98712.68653.87
Income Availableto Com Incl Extra Ord 816.17587.98712.68653.87
Diluted Net Income 816.17587.98712.68653.87
Diluted Weighted Average Shares 12.6012.8112.9713.06
Diluted EPS Excluding Extra Ord Items 64.7745.8954.9650.06
DPS- Common Stock Primary Issue 10.007.006.336.33
Diluted Normalized EPS 64.7746.2755.4450.60
Interest Exp( Inc) Net- Operating Total -4.904.904.90
Gain( Loss)on Saleof Assets --61.90-38.70-22.10
Unusual Expense( Income) --3.987.56
Total Adjustmentsto Net Income ---0.10-
*All figures in crores except per share values
Recommended For You
Trending Stocks
2,495.00+49.80(2.04%)
953.75+8.00(0.85%)
2,504.50-9.95 (-0.40%)
12,600.00-43.85 (-0.35%)
HomeMarketsPremiumFor youGet App